Search Contract Opportunities

ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS   3

ID: BAA-DAIT-75N93021R00008 • Type: Solicitation • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Solicitation for BAA-DAIT-75N93021R00008 entitled, "Advancing Vaccine Adjuvant Research for Tuberculosis (TB)"

Background
The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a solicitation for advancing vaccine adjuvant research for tuberculosis (TB). The goal is to enhance scientific understanding and development of vaccine adjuvants to combat TB.

Work Details
Contractors are required to furnish all necessary services, qualified personnel, material, equipment, and facilities to perform the Statement of Work. Offerors must develop their own SOW based on provided research and technical objectives. Reporting requirements include monthly, annual, and final technical progress reports, financial conflict of interest reports, source code delivery, Section 508 compliance reports, and invention reporting. Contractors must adhere to NIH policies on rigor and transparency in research.

Place of Performance
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of Allergy, Immunology, and Transplantation, 5601 Fishers Lane, Rockville, MD 20852.

Overview

Agency
National Institutes of Health (NIH) [HHS]
Response Deadline
Aug. 10, 2021, 3:00 p.m. EDT Past Due
Posted
April 28, 2021, 12:41 p.m. EDT (updated: July 7, 2021, 1:24 p.m. EDT)
Set Aside
None
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 - Health R&D Services; Health Care Services; Applied Research
Place of Performance
United States
Source
Open
Current SBA Size Standard
1000 Employees
Pricing
Fixed Price
Evaluation Criteria
Best Value
Est. Level of Competition
Average
On 4/28/21 National Institutes of Health issued Solicitation BAA-DAIT-75N93021R00008 for ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS due 8/10/21. The opportunity was issued full & open with NAICS 541714 and PSC AN12.
Primary Contact
Name
Emily Bannister   Profile
Email
emily.bannister@nih.gov
Phone
(240) 669-5135

Secondary Contact

Name
Tom Bahrami   Profile
Email
bahramit@niaid.nih.gov
Phone
(240) 669-5147

Documents

Posted documents for Solicitation BAA-DAIT-75N93021R00008

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation BAA-DAIT-75N93021R00008

Award Notifications

Agency published notification of awards for Solicitation BAA-DAIT-75N93021R00008

Contract Awards

Prime contracts awarded through Solicitation BAA-DAIT-75N93021R00008

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation BAA-DAIT-75N93021R00008

Similar Active Opportunities

Open contract opportunities similar to Solicitation BAA-DAIT-75N93021R00008

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NATIONAL INSTITUTES OF HEALTH NIAID
FPDS Organization Code
7529-00310
Source Organization Code
100188096
Last Updated
Aug. 25, 2021
Last Updated By
bahramit@niaid.nih.gov
Archive Date
Aug. 25, 2021